Skip to main content

Table 2 Comparison of glucose metabolism indexes of three groups

From: Characteristics of glucose metabolism indexes and continuous glucose monitoring system (CGMS) in patients with insulinoma

Variables

Insulinoma group (n = 44)

Hypoglycemia group (n = 26)

Control group (n = 31)

F value

P value

HBG (mmol/L)

9.00 ± 3.10

9.65 ± 4.47

8.27 ± 1.51

0.95

0.628

LBG (mmol/L)*

2.76 ± 0.92

3.93 ± 0.75

4.67 ± 0.63

9.74

0.001

MBG (mmol/L)

5.10 ± 1.20

5.99 ± 1.63

5.83 ± 0.66

2.86

0.085

SD

1.46 ± 0.79

1.25 ± 1.15

0.92 ± 0.28

1.03

0.526

HbA1c (%)

4.97 ± 0.50

5.27 ± 0.39

5.52 ± 0.21

2.14

0.101

FBG (mmol/L)*

3.37 ± 1.29

4.83 ± 0.40

4.74 ± 0.37

14.72

0.000

FINS (mU/L)*

22.63 ± 15.09

8.04 ± 6.19

8.60 ± 3.60

10.72

0.000

FCP (ng/mL)*

3.17 ± 1.18

2.17 ± 1.04

2.23 ± 0.69

5.07

0.011

IRI*

0.45 ± 0.36

0.09 ± 0.07

0.10 ± 0.05

12.80

0.000

  1. HBG high blood glucose, LBG low blood glucose, MBG mean blood glucose, SD standard deviation, HbA1c glalycosylated hemoglobin A1c, FBG fasting blood glucose, FINS fasting insulin, FCP fasting C-peptide, IRI Insulin Release Index
  2. *P < 0.05